Erin Quirk

Insider Reports History

Entity
Individual
Location
C/O Terns Pharmaceuticals, Inc., 1065 East Hillsdale Blvd., Suite 100, Foster City, CA
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Erin Quirk
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erin Quirk:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Terns Pharmaceuticals, Inc. President, Head of R&D Common Stock 75K $284K $3.78 Jan 23, 2024 Direct
Terns Pharmaceuticals, Inc. President, Head of R&D Stock Option (Right to Buy) 150K Jan 23, 2024 Direct

Insider Reports Filed by Erin Quirk

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TERN Terns Pharmaceuticals, Inc. Jan 23, 2024 2 $0 4 Jan 25, 2024 President, Head of R&D
TERN Terns Pharmaceuticals, Inc. Feb 1, 2023 1 $0 4 Feb 3, 2023 President, Head of R&D
TERN Terns Pharmaceuticals, Inc. Jan 26, 2022 1 $0 4 Jan 28, 2022 President, CMO and Head of R&D
TERN Terns Pharmaceuticals, Inc. Sep 28, 2021 1 $0 4 Sep 30, 2021 President and CMO